However, compared with WT–IDH cells that are dominated by glycolysis [255,256], IDH mutant tumour cells have a stronger TCA cycle [256,257,258], more OXPHOS [259], and lower glycolysis levels [256,260,261]. The gene discussed is IDH2; the disease is neoplasm.